← Eichor
Study identifier: NCT06100991 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry

Condition: Generalized Pustular Psoriasis  ·  Sponsor: CorEvitas

PhaseN/A
Planned participants200
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

Prospective, observational registry for subjects with GPP under the care of a dermatology investigator.Approximately 200 subjects and 75 clinical sites in North America will be recruited to participate with no defined upper limit for either target

This description comes directly from the study's public registry record.

Talk to the study team

Cathy Cheney  ·  +1 508 408 5433  ·  corevitasregistrytrials@corevitas.com

Jeffrey Greenberg, MD

Always discuss trial participation with your own doctor first.

Locations (1)

CorEvitas, LLCWaltham, Massachusetts, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06100991